Kuempers, C.
van der Linde, L. I. S.
Reischl, M.
Vogel, W.
Stellmacher, F.
Reck, M.
Heigener, D.
Rabe, K. F.
Kirfel, J.
Perner, S.
Welker, L.
Article History
Received: 9 May 2019
Revised: 4 July 2019
Accepted: 22 July 2019
First Online: 7 August 2019
Compliance with ethical standards
:
: SP is a consultant of Ventana, Roche, Novartis, Astellar, Astrazeneca, Bristol-Myers Squibb, Merck Serono, and MSD. JK is a consultant of Roche, Novartis, BMS, and MSD. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The above mentioned companies had no influence on the study design, acquisition of data, or writing of the manuscript.